Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
10/2005
10/06/2005WO2005092887A1 Compounds for the treatment of diseases
10/06/2005WO2005092882A1 4-amino-5-halogeno-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, cns, neurological and cardiovascular disorders
10/06/2005WO2005092841A1 Compounds having beta-agonist activity
10/06/2005WO2005092840A1 Formamide derivatives useful as adrenoceptor
10/06/2005WO2005092832A1 Method of producing aminophenol compounds
10/06/2005WO2005092011A2 Mitotic kinesin inhibitors
10/06/2005WO2005075420A3 Pyrrolidine derivatives acting as ccr3-receptor antagonists
10/06/2005WO2004072031A8 Phenylacetamides and their use as glucokinase modulators
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222395 New peptide derivatives
10/06/2005US20050222243 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/06/2005US20050222208 Novel process for amorphous form of donepezil hydrochloride
10/06/2005US20050222205 Treatment of pain with ifendropil
10/06/2005US20050222204 Therapy for obesity; using secondary amino compound; antidiabetic agents; irritable bowel syndrome; nausea, antidepressants, drug abuse
10/06/2005US20050222200 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/06/2005US20050222187 A quaternary ammonium salts of 1-{2-(3'-chlorobiphenyl-4-yl)-2-oxoethyl}-4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydropyridine for treating neurodegenerative disorders; chemical synthesis; mixture with other active ingredients; Alzheimer's disease, cerebral edema, brain and nervous system disorders
10/06/2005US20050222146 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
10/06/2005US20050222145 Cathepsin S inhibitors
10/06/2005US20050222140 Improved DP-IV inhibitors increase the steady state concentrations of GLP-1 and GIP, resulting in improved glucose tolerance
10/06/2005US20050222137 Combination of organic compounds
10/06/2005CA2560368A1 Compounds for the treatment of diseases
10/06/2005CA2560213A1 Mitotic kinesin inhibitors
10/05/2005EP1581530A1 Indane compounds as ccr5 antagonists
10/05/2005EP1581514A2 Chemical compounds
10/05/2005EP1581511A1 Ccr8 inhibitors
10/05/2005EP1581497A2 Mitotic kinesin inhibitors
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581495A1 Piperidine amine compounds and their use
10/05/2005EP1581493A1 Factor xa inhibitors
10/05/2005EP1183233B1 Bradykinin receptor antagonists
10/05/2005EP0775110B1 Arylthio compounds as antibacterial and antiviral agents
10/05/2005CN1678591A New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
10/05/2005CN1678584A Organic acid salt of amlodipine
10/05/2005CN1678583A Organic acid salt of amlodipine
10/05/2005CN1678582A New benzoyl piperidine compounds
10/05/2005CN1678317A 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/05/2005CN1678316A Piperidin-2, 6-dione pamoate salts and their use for the treatment of stress-related affective disorders
10/04/2005US6951961 Methods of use and compositions for the diagnosis and treatment of infectious disease
10/04/2005US6951940 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders
10/04/2005US6951874 Compounds
10/04/2005US6951872 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
10/04/2005US6951862 Calcium channel blockers comprising two benzhydril moieties
10/04/2005CA2238275C Metalloproteinase inhibitors
09/2005
09/29/2005WO2005090350A1 Substituted piperidine compounds and methods of their use
09/29/2005WO2005090347A1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors
09/29/2005WO2005090307A1 A process for the synthesis of amine ethers
09/29/2005WO2005090300A1 Novel benzyl(idene)-lactam derivatives
09/29/2005WO2005090296A2 N-substituted benzene sulfonamides
09/29/2005WO2005090294A2 PROCESS OF MAKING α-AMINOOXYKETONE/α-AMINOOXYALDEHYDE AND α-HYDROXYKETONE/α-HYDROXYALDEHYDE COMPOUNDS AND A PROCESS OF MAKING REACTION PRODUCTS FROM CYCLIC α,ß-UNSATURATED KETONE SUBSTRATES AND NITROSO SUBSTRATES
09/29/2005WO2005090282A1 Androgen receptor modulator compounds and methods
09/29/2005WO2005089759A1 Derivatives of piperidinylalkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005089511A2 Novel pharmaceutical forms, and methods of making and using the same
09/29/2005WO2005089353A2 (s)-amlodipine malate
09/29/2005WO2005074513A3 N-benzyl-3,4-dihyroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4-carboxamide compounds useful as hiv integrase inhibitors
09/29/2005WO2005060947A3 Agonist and antagonist ligands of the nociceptin receptor
09/29/2005US20050215825 Hydroaminomethylation of an olefin, a primary or secondary amine with a catalyst of a neutral rhodium-monodentate phosphite ligand complex prepared by contacting a neutral rhodium procatalyst with a monodentate phosphite ligand; chemical intermediate for ibutilide, terfenadine, and fexofenadine
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215691 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays
09/29/2005US20050215637 Tuberculosis treatment
09/29/2005US20050215591 Novel crystalline forms of donepezil hydrochloride
09/29/2005US20050215590 Formamide derivatives for the treatment of diseases
09/29/2005US20050215589 Inhibitors of 5-HT2A receptor
09/29/2005US20050215587 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions
09/29/2005US20050215549 TACE inhibitors
09/29/2005US20050215513 Use of an antiviral compound linked to one or more phosphonate groups in hepatitis C treatment; improved bioavailability, side effect reduction; antiviral compound is a 2-(2-isopropylaminothiazol-4-yl)-4-(tricyclic fused ring)-7-methoxy-quinoline compound
09/29/2005DE102004012365A1 Substituierte Dihydropyridine Substituted dihydropyridines
09/29/2005CA2559047A1 N-substituted benzene sulfonamides
09/29/2005CA2554610A1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors
09/29/2005CA2554608A1 Derivatives of piperidinylalkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/28/2005EP1578724A2 Mitotic kinesin inhibitors
09/28/2005EP1578425A1 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
09/28/2005EP1578353A2 Methods of use and compositions for the diagnosis and treatment of infectious disease
09/28/2005EP1037875B1 Method for producing salts of cyclic amidines
09/28/2005EP1000085B1 Treatment of insulin resistance with growth hormone secretagogues
09/28/2005EP0963200B1 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid
09/28/2005CN1675300A Beta-nucleating, light stabilizing agents for polypropylene
09/28/2005CN1675221A Process for producing cyclic thioether and synthetic intermediate thereof
09/28/2005CN1675201A N-substituted piperidine derivatives as serotonin receptor agents
09/28/2005CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals
09/28/2005CN1674900A N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B secretion
09/28/2005CN1673218A Organic electronic material containing hindered amine group and spiro structure unit and its synthesis process
09/28/2005CN1220683C Acyl derivatives for treating VLA-4 related disorders
09/28/2005CN1220679C Preparation of thiol carbamate and thiocyanic ester compound
09/27/2005US6949656 Cyclic amine derivatives and use thereof
09/27/2005US6949655 Acyclic piperidine derivatives
09/27/2005US6949650 Process for the racemization of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2-3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine
09/27/2005US6949554 Calcium channel blockers comprising two benzhydril moieties
09/27/2005US6949546 N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity
09/27/2005US6949545 Tissue remodeling; antiinflammatory agents; autoimmune disease
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/27/2005CA2299355C Aryloxyarylsulfonylamino hydroxamic acid derivatives
09/22/2005WO2005087740A1 Fluorenone 1, 4,-dihydropyridin derivatives
09/22/2005WO2005087739A1 Biphenyl compounds useful as muscarinic receptor antagonists
09/22/2005WO2005087738A1 Biphenyl compounds useful as muscarinic receptor antagonists
09/22/2005WO2005087737A1 Biphenyl compounds useful as muscarinic receptor antagonists
09/22/2005WO2005087736A1 Biphenyl compounds useful as muscarinic receptor antagonists
09/22/2005WO2005087735A1 Biphenyl compounds useful as muscarinic receptor antagonists
09/22/2005WO2005087734A1 Biphenyl compounds useful as muscarinic receptor antagonists
09/22/2005WO2005087733A1 Biphenyl compounds useful as muscarinic receptor antagonists
09/22/2005WO2005087732A1 Biphenyl compounds useful as muscarinic receptor antagonists
1 ... 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 ... 380